INTERNATIONAL PATENT: VENTUS THERAPEUTICS U.S., INC., DORICH, STEPHANE, CIBLAT, STEPHANE FILES APPLICATION FOR "LACTAM DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF"

GENEVA, May 28 -- VENTUS THERAPEUTICS U.S., INC. (100 Beaver Street, Suite 201Waltham, Massachusetts 02453), DORICH, Stephane (124 avenue PendennisPointe-Claire, Quebec H9R 1H6), CIBLAT, Stephane (1260 rue Pauline-JulienMontreal, Quebec H2J 0A2) filed a patent application (PCT/US2024/056195) for "LACTAM DERIVATIVES FOR INHIBITING NLRP3 AND USES THEREOF" on Nov 15, 2024. With publication no. WO/2025/106863, the details related to the patent application was published on May 22, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): VENTUS THERAPEUTICS U.S., INC. (100 Beaver Street, Suite 201Waltham, ...